321
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Liposome-encapsulated midazolam for oral administration

, , , &
Pages 166-172 | Received 01 Feb 2010, Accepted 31 May 2010, Published online: 04 Aug 2010

References

  • Andersin, R. (1991). Solubility and acid-base behaviour of midazolam in media of different pH, studied by ultraviolet spectrophotometry with multicomponent software. J Pharm Biomed Anal 9:451–455.
  • Boogaerts, J. G., Lafont, N. D., Luo, H., Legros, F. J. (1993). Plasma concentrations of bupivacaine after brachial plexus administration of liposome-associated and plain solutions to rabbits. Can J Anaesth 40:1201–1204.
  • Brosius, K. K., Bannister, C. F. (2002). Oral midazolam premedication in preadolescents and adolescents. Anesth Analg 94:31–36.
  • Clark, M. A., Hirst, B. H., Jepson, M. A. (2000). Lectin-mediated mucosal delivery of drugs and microparticles. Adv Drug Deliv Rev 4:207–223.
  • de Araujo, D. R., Cereda, C. M., Brunetto, G. B., Pinto, L. M., Santana, M. H., de Paula, E. (2004). Encapsulation of mepivacaine prolongs the analgesia provided by sciatic nerve blockade in mice. Can J Anaesth 51:566–572.
  • Fisher, R., Hung, O., Mezei, M., Stewart, R. (1998). Topical anaesthesia of intact skin: liposome-encapsulated tetracaine vs. EMLA. Br J Anaesth 81:972–973.
  • Feld, L. H., Negus, J. B., White, P. F. (1990). Oral midazolam preanesthetic medication in pediatric outpatients. Anesthesiology 73:831–834.
  • Foldvari, M., Gesztes, A., Mezei, M. (1990). Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J Microencapsul 7:479–489.
  • Goto, J., Araki, H., Otomo, S., Aihara, H. (1986). A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats. Drugs Exp Clin Res 12:917–921.
  • Grant, G. J., Vermeulen, K., Langerman, L., Zakowski, M., Turndorf, H. (1994). Prolonged analgesia with liposomal bupivacaine in a mouse model. Reg Anesth 19:264–269.
  • Hung, O. R., Whynot, S. C., Varvel, J. R., Shafer, S. L., Mezei, M. (1995). Pharmacokinetics of inhaled liposome-encapsulated fentanyl. Anesthesiology 83:277–284.
  • Isik, B., Baygin, O., Bodur, H. (2008). Effect of drinks that are added as flavoring in oral midazolam premedication on sedation success. Paediatr Anaesth 18:494–500.
  • Kain, Z. N., Mayes, L. C., Bell, C., Weisman, S., Hofstadter, M. B., Rimar, S. (1997). Premedication in the United States: a status report. Anesth Analg 84:427–432.
  • Kain, Z. N., Hofstadter, M. B., Mayes, L. C., Krivutza, D. M., Alexander, G., Wang, S. M., et al. (2000). Midazolam: effects on amnesia and anxiety in children. Anesthesiology 93:676–684.
  • Karanth, H., Murthy, R. S. (2007). PH-sensitive liposomes—principle and application in cancer therapy. J Pharm Pharmacol 59:469–483.
  • Kuzma, P. J., Kline, M. D., Calkins, M. D., Staats, P. S. (1997). Progress in the development of ultra-long-acting local anesthetics. Reg Anesth 22:543–551.
  • Lopez-Berestein, G., Hopfer, R. L., Mehta, R., Mehta, K., Hersh, E. M., Juliano, R. L. (1984). Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis 150:278–283.
  • Malinovsky, J. M., Benhamou, D., Alafandy, M., Mussini, J. M., Coussaert, C., Couarraze, G., et al. (1997). Neurotoxicological assessment after intracisternal injection of liposomal bupivacaine in rabbits. Anesth Analg 85:1331–1336.
  • Malinovsky, J. M., Le Corre, P., Meunier, J. F., Chevanne, F., Pinaud, M., Leverge, R., et al. (1999). A dose-response study of epidural liposomal bupivacaine in rabbits. J Contr Rel 60:111–119.
  • Marshall, J., Rodarte, A., Blumer, J., Khoo, K. C., Akbari, B., Kearns, G. (2000). Pediatric pharmacodynamics of midazolam oral syrup. Pediatric Pharmacology Research Unit Network. J Clin Pharmacol 40:578–589.
  • Mashimo, T., Uchida, I., Pak, M., Shibata, A., Nishimura, S., Inagaki, Y., et al. (1992). Prolongation of canine epidural anesthesia by liposome encapsulation of lidocaine. Anesth Analg 74:827–834.
  • Mowat, J. J., Mok, M. J., MacLeod, B. A., Madden, T. D. (1996). Liposomal bupivacaine. Extended duration nerve blockade using large unilamellar vesicles that exhibit a proton gradient. Anesthesiology 85:635–643.
  • Mura, P., Maestrelli, F., Gonzalez-Rodriguez, M. L., Michelacci, I., Ghelardini, C., Rabasco, A. M. (2007). Development, characterization, and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm 67:86–95.
  • Nakamura, T., Okada, K., Nagata, K., Yamazoe, Y. (2000). Intestinal cytochrome P450 and response to rifampicin in rabbits. Jpn J Pharmacol 82:232–239.
  • Nishimura, T., Amano, N., Kubo, Y., Ono, M., Kato, Y., Fujita, H., et al. (2007). Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey. Drug Metab Dispos 35:1275–1284.
  • Nordt, S. P., Clark, R. F. (1997). Midazolam: a review of therapeutic uses and toxicity. J Emerg Med 15:357–365.
  • Nounou, M. M., El-Khordagui, L. K., Khalafallah, N. (2005). Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles. Acta Pol Pharm 62:369–379.
  • Payne, K., Mattheyse, F. J., Liebenberg, D., Dawes, T. (1989). The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol 37:267–272.
  • Peltier, S., Oger, J. M., Lagarce, F., Couet, W., Benoit, J. P. (2006). Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm Res 23:1243–1250.
  • Reves, J. G., Glass, P. S. A., Lubarsky, D. A., McEvoy, M. D. (2005). Intravenous nonopioid anesthetics. In: Miller, R.D. (Ed.), Miller’s anesthesia, 6th ed. (pp 317–378). Philadelphia, Pennsylvania, USA: Elsevier Churchill Livingstone.
  • Sakuda, S., Akabane, T., Teramura, T. (2006). Marked species differences in the bioavailability of midazolam in cynomolgus monkeys and humans. Xenobiotica 36:331–340.
  • Schumacher, I., Margalit, R. (1997). Liposome-encapsulated ampicillin: physicochemical and antibacterial properties. J Pharm Sci 86:635–641.
  • Senior, J. H., Trimble, K. R., Maskiewicz, R. (1991). Interaction of positive-charged liposomes with blood: implications for their application in vivo. Biochim Biophys Acta 1070:173–179.
  • Wermeling, D. P., Record, K. A., Kelly, T. H., Archer, S. M., Clinch, T., Rudy, A. C. (2006). Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers. Anesth Analg 103:344–349.
  • White, P. F., Freire, A. R. (2005). Ambulatory (outpatient) anesthesia. In: Miller, R.D. (Ed.), Miller’s anesthesia, 6th ed. (pp 2589–2635). Philadelphia, Pennsylvania, USA: Elsevier Churchill Livingstone.
  • Yamaoka, K., Tanigawara, Y., Nakagawa, T., Uno, T. (1981). A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4:879–885.
  • Yuen, V. M., Hui, T. W., Irwin, M. G., Yuen, M. K. (2008). A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded, randomized, controlled trial. Anesth Analg 106:1715–1721.
  • Zhang, N., Ping, Q. N., Huang, G. H., Xu, W. F. (2005). Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm 94:247–259.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.